⌘K

Home/Filings/4/0001209191-22-037934

4//SEC Filing

Allison David D. 4

Accession 0001209191-22-037934

CIK 0001445499other

View on SEC.gov Company Profile

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 5:00 PM ET

Size

5.3 KB

Accession

0001209191-22-037934

Insider Transaction Report

Form 4

Period: 2022-06-16

IMPEL PHARMACEUTICALS INCIMPL

Allison David D.

Director

Transactions

Award
Stock Option (right to buy)
2022-06-16+12,789→ 12,789 total
Exercise: $8.65Exp: 2032-06-15→ Common Stock (12,789 underlying)

Footnotes (1)

[F1]The option is 100% vested on June 16, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IMPEL PHARMACEUTICALS INC

CIK 0001445499

Entity typeother

Related Parties

1

filerCIK 0001853903

Filing Metadata

Form type: 4
Filed: Jun 16, 8:00 PM ET
Accepted: Jun 17, 5:00 PM ET
Size: 5.3 KB

View on SEC.gov